CTO’s Vision for a More Accessible Dementia Diagnosis | Sysmex [Video]

At Sysmex, we aim to provide new value to all individuals at every stage of their lifelong healthcare journey through early detection of disease, disease prevention, and selection of optimal treatment. In an interview, our Chief Technology Officer, Tomokazu Yoshida, talks about his determination and his struggle to establish a new testing method in the field of dementia, through innovative, minimally invasive blood testing technology.

▶The Quest for a More Accessible Dementia Diagnosis – How Testing Can Support a Better Healthcare Journey for Patients – (Sysmex Corporate Website Stories Article) https://www.sysmex.co.jp/en/stories/240301.html

#Sysmex #Dementia #AlzheimersDisease #EarlyDiagnosis #BloodTesting #healthcarejourney

*”Healthcare journey” is a trademark of Sysmex Corporation, registered in Japan.